Skip to main content
. 2021 Jan 21;22(3):1051. doi: 10.3390/ijms22031051
amyloid-β
AD Alzheimer’s disease
ANOVA analysis of variance
BBB blood-brain barrier
CNS central nervous system
DMSO dimethylsulfoxide
HFIP hexafluoroisopropanol
MD molecular dynamics
MOE Molecular Environment
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide
mAb monoclonal antibody
SMFS single-molecule force spectroscopy